Apazol A 40 mg želučanootporne tablete
| Name | Apazol A 40 mg želučanootporne tablete |
|---|---|
| Former Name | Pantoprazol mibe 40 mg želučanootporne tablete |
| Marketing Authorisation Number | HR-H-004635539 |
| Active Substance | pantoprazolnatrij seskvihidrat |
| Composition | svaka želučanootporna tableta sadrži 40 mg pantoprazola u obliku pantoprazolnatrij seskvihidrata |
| Pharmaceutical Form | želučanootporna tableta |
| Packaging [MA Number for Packaging] | 5 tableta u blisteru, u kutiji [HR-H-004635539-01] 7 tableta u blisteru, u kutiji [HR-H-004635539-02] 14 tableta u blisteru, u kutiji [HR-H-004635539-03] 15 tableta u blisteru, u kutiji [HR-H-004635539-04] 28 tableta u blisteru, u kutiji [HR-H-004635539-05] 30 tableta u blisteru, u kutiji [HR-H-004635539-06] 56 tableta u blisteru, u kutiji [HR-H-004635539-07] 60 tableta u blisteru, u kutiji [HR-H-004635539-08] 98 tableta u blisteru, u kutiji [HR-H-004635539-09] 100 tableta u blisteru, u kutiji [HR-H-004635539-10] 15 tableta u bočici, u kutiji [HR-H-004635539-11] 30 tableta u bočici, u kutiji [HR-H-004635539-12] 60 tableta u bočici, u kutiji [HR-H-004635539-13] 100 tableta u bočici, u kutiji [HR-H-004635539-14] |
| Manufacturer | mibe GmbH Arzneimittel, Brehna, Njemačka |
| Marketing Authorisation Holder | Mibe Pharmaceuticals d.o.o., Zavrtnica 17, Zagreb, Hrvatska |
| Marketing Authorisation Date | 21.01.2020 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/18-02/84 |
| Registration Number | 381-12-01/30-20-12 |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | A02BC02 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
